Impact of label-free technologies in head and neck cancer circulating tumour cells

Oncotarget

Volumn 7, Issue 44, 2016, Pages 71223-71234

  Kulasinghe, Arutha ^a   Kenny, Liz ^b   Perry, Chris ^c   Thiery, Jean Paul ^d   Jovanovic, Lidija ^a   Vela, Ian ^a,c   Nelson, Colleen ^a   Punyadeera, Chamindie ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CellSearch; Circulating tumour cells; Head and neck cancers; Label free capture; Metastasis

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; EPITOPE;

ADULT; ADVANCED CANCER; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CELL CULTURE TECHNIQUE; CELLULAR PARAMETERS; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; VERY ELDERLY; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR EMBOLISM;

ADULT; AGED; CELL LINE, TUMOR; EPITOPES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 84995467545     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12086     Document Type: Article

References (41)

1. Schmidt H, Kulasinghe A, Perry C, Nelson C, Punyadeera C. A liquid biopsy for head and neck cancers. Expert review of molecular diagnostics. 2016;16: 165-172
2. He S, Li P, He S, Long T, Zhang N, Fang J, Yu Z. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results. The Journal of laryngology and otology 2013;127: 788-793
3. Jatana KR, Teknos TN, Chalmers JJ, Balasubramanian P, Lang JC, Yang LY, Jatana CA, White E, Agrawal A, Ozer E, Schuller DE. Significance of Circulating Tumor Cells in Patients With Squamous Cell Carcinoma of the Head and Neck. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY. 2010;136: 1274-1279
4. Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. JAMA otolaryngology-head & neck surgery. 2015;141: 457-462
5. O'Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee N, Riaz N, Pei X, Koyfman SA, Adelstein D, Burkey BB, Friborg J et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. The Lancet Oncology. 2016
6. Chai RC, Lambie D, Verma M, Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer medicine. 2015;4: 596-607
7. Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A et al. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. Journal of clinical oncology. 2015;33: 836-845
8. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC et al. Human papillomavirus and survival of patients with oropharyngeal cancer. The New England journal of medicine. 2010;363: 24-35
9. O'Sullivan B, Huang SH, Perez-Ordonez B, Massey C, Siu LL, Weinreb I, Hope A, Kim J, Bayley AJ, Cummings B, Ringash J, Dawson LA, Cho BC et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiotherapy and oncology. 2012;103: 49-56
10. Huang SH, Perez-Ordonez B, Liu FF, Waldron J, Ringash J, Irish J, Cummings B, Siu LL, Kim J, Weinreb I, Hope A, Gullane P, Brown D et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. International journal of radiation oncology, biology, physics. 2012;82: 276-283
11. Misiukiewicz K, Camille N, Gupta V, Bakst R, Teng M, Miles B, Genden E, Sikora A, Posner M. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck. Clinical advances in hematology & oncology. 2014;12: 812-819
12. Kulasinghe A, Perry C, Jovanovic L, Nelson C, Punyadeera C. Circulating tumour cells in metastatic head and neck cancers. International journal of cancer. 2015;136: 2515-2523
13. Hillig T, Horn P, Nygaard AB, Haugaard AS, Nejlund S, Brandslund I, Soletormos G. In vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods. Tumour biology. 2015
14. Khoo BL, Lee SC, Kumar P, Tan TZ, Warkiani ME, Ow SG, Nandi S, Lim CT, Thiery JP. Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget. 2015; doi: 10.18632/oncotarget.3903
15. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Scott SL et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158: 1110-1122
16. McInnes LM, Jacobson N, Redfern A, Dowling A, Thompson EW, Saunders CM. Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity. Frontiers in oncology. 2015;5: 42
17. Pantel K, Alix-Panabieres C. Real-time liquid biopsy in cancer patients: fact or fiction? Cancer research. 2013;73: 6384-6388
18. Alix-Panabieres C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clinical chemistry. 2013;59: 110-118
19. Bozec A, Ilie M, Dassonville O, Long E, Poissonnet G, Santini J, Chamorey E, Ettaiche M, Chauviere D, Peyrade F, Hebert C, Benezery K, Sudaka A et al. Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. European archives of oto-rhinolaryngology. 2013;270: 2745-2749
20. Duray A, Lacremans D, Demoulin S, Delvenne P, Saussez S. Prognosis of HPV-positive head and neck cancers: implication of smoking and immunosuppression. Advances in Cellular and Molecular Otolaryngology. 2014;2: 25717
21. Chai RC, Lim Y, Frazer IH, Wan Y, Perry C, Jones L, Lambie D, Punyadeera C. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients. BMC cancer. 2016;16: 178
22. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical cancer research. 2004;10: 6897-6904
23. Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, Wongvipat J, Kossai M, Ramazanoglu S et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159: 176-187
24. Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, Clevers H. Organoid culture systems for prostate epithelial and cancer tissue. Nature protocols. 2016;11: 347-358
25. Gasch C, Plummer PN, Jovanovic L, McInnes LM, Wescott D, Saunders CM, Schneeweiss A, Wallwiener M, Nelson C, Spring KJ, Riethdorf S, Thompson EW, Pantel K et al. Heterogeneity of miR-10b expression in circulating tumor cells. Scientific reports. 2015;5: 15980
26. Kulasinghe A, Perry C, Warkiani ME, Blick T, Davies A, O'Byrne K, Thompson EW, Nelson CC, Vela I, Punyadeera C. Short term ex-vivo expansion of circulating head and neck tumour cells. Oncotarget. 2016; doi: 10.18632/oncotarget.11159
27. Hristozova T, Konschak R, Stromberger C, Fusi A, Liu Z, Weichert W, Stenzinger A, Budach V, Keilholz U, Tinhofer I. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Annals of oncology. 2011;22: 1878-1885
28. Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnology and bioengineering. 2009;102: 521-534
29. Hristozova T, Konschak R, Budach V, Tinhofer I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry Part A. 2012;81: 489-495
30. Balasubramanian P, Yang L, Lang JC, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ. Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells. Molecular pharmaceutics. 2009;6: 1402-1408
31. Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert review of molecular diagnostics. 2016;16: 147-164
32. Hendrix MJ, Seftor EA, Seftor RE, Chao JT, Chien DS, Chu YW. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacology & therapeutics. 2016;159: 83-92
33. Desitter I, Guerrouahen BS, Benali-Furet N, Wechsler J, Janne PA, Kuang Y, Yanagita M, Wang L, Berkowitz JA, Distel RJ, Cayre YE. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer research. 2011;31: 427-441
34. Kulemann B, Pitman MB, Liss AS, Valsangkar N, Fernandez-Del Castillo C, Lillemoe KD, Hoeppner J, Mino-Kenudson M, Warshaw AL, Thayer SP. Circulating tumor cells found in patients with localized and advanced pancreatic cancer. Pancreas. 2015;44: 547-550
35. Fina E, Reduzzi C, Motta R, Di Cosimo S, Bianchi G, Martinetti A, Wechsler J, Cappelletti V, Daidone MG. Did circulating tumor cells tell us all they could? The missed circulating tumor cell message in breast cancer. The International journal of biological markers. 2015;30: e429-433
36. Buglione M, Grisanti S, Almici C, Mangoni M, Polli C, Consoli F, Verardi R, Costa L, Paiar F, Pasinetti N, Bolzoni A, Marini M, Simoncini C et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to nonsurgical treatment and survival. European journal of cancer (Oxford, England: 1990). 2012;48: 3019-3026
37. Nichols AC, Lowes LE, Szeto CC, Basmaji J, Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond A, Palma DA, Winquist E, Ernst S et al. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system. Head & neck. 2012;34: 1440-1444
38. Xu L, Mao X, Imrali A, Syed F, Mutsvangwa K, Berney D, Cathcart P, Hines J, Shamash J, Lu YJ. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System. PloS one. 2015;10: e0138032
39. Janssen Diagnostics LLC. CTCs Above or Below a Predetermined CutoffNumber Predicit Prognosis, vol. 2016, 2016
40. Warkiani ME, Khoo BL, Wu L, Tay AK, Bhagat AA, Han J, Lim CT. Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics. Nature protocols. 2016;11: 134-148
41. Ramirez JM, Fehm T, Orsini M, Cayrefourcq L, Maudelonde T, Pantel K, Alix-Panabieres C. Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients. Clinical chemistry. 2014;60: 214-221